Profil
Armin Kiser is associated with Translumina GmbH and Translumina Therapeutics LLP as Managing Director and Chief Operating Officer-Europe & Managing Director respectively.
Postes actifs de Armin Kiser
| Sociétés | Poste | Début |
|---|---|---|
Translumina Therapeutics LLP
 Translumina Therapeutics LLP Medical SpecialtiesHealth Technology Translumina Therapeutics LLP engages in the provision of healthcare solutions. It manufactures and markets Yukon Choice PC and Yukon Choice Flex to the physicians and patients for clinical outcomes and cardiac disorders. The company was founded by Punita Sharma Arora and Gurmit Singh Chugh in 2010 and is headquartered in New Delhi, India. | Corporate Officer/Principal | 10/10/2022 |
Translumina GmbH
 Translumina GmbH Medical SpecialtiesHealth Technology Part of Translumina Therapeutics LLP, Translumina GmbH is a German company that manufactures cardiovascular medical devices. The company is based in Hechingen, Germany. The company was founded in 2000. Armin Kiser has been the CEO of the company since 2022. | Directeur Général | 01/10/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Translumina Therapeutics LLP
Translumina Therapeutics LLP Medical SpecialtiesHealth Technology Translumina Therapeutics LLP engages in the provision of healthcare solutions. It manufactures and markets Yukon Choice PC and Yukon Choice Flex to the physicians and patients for clinical outcomes and cardiac disorders. The company was founded by Punita Sharma Arora and Gurmit Singh Chugh in 2010 and is headquartered in New Delhi, India. | Health Technology |
Translumina GmbH
Translumina GmbH Medical SpecialtiesHealth Technology Part of Translumina Therapeutics LLP, Translumina GmbH is a German company that manufactures cardiovascular medical devices. The company is based in Hechingen, Germany. The company was founded in 2000. Armin Kiser has been the CEO of the company since 2022. | Health Technology |
